HLB Pharmaceutical Co., Ltd.

₩7,570As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:047920Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 4.08%
Div yield —
ROE 2.17%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.20
PE TTM 91.06
TSR TTM (46.55%)
Mkt cap ₩248.3B
ROIC 1.22%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩8,519
12.53%
(86.60%)
Hold 10|9|10|7|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
198.53
217.51
236.74
251.82
16.85%
24.45%
36.80%
35.05%
Revenue₩B
12.23
12.61
12.35
12.41
(1.80%)
1.48%
(0.17%)
0.20%
Peers (US$183.1M)
Cap (US$)
PE
146.6M
9.191x
144.0M
4.986x
Capital
TTM
5Y
10Y
Leveragex
2.158
0.033
0.031
EBIT/Intx
0.701
0.248
0.234
Own earn%
21.83
2.41
(10.36)
Sh yield%
25.95
21.19
24.84
Owners
Insiders/Inst%
0.17
50.35
Short interest%
0.69
SBC / revenue%
0.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
4–14
$1 testx
—
Incr. ROIC%
9